Abstract
AI chatbots powered by large language models (LLMs) are emerging as an important source of public-facing medical information. Generative models hold promise for producing tailored guidance at scale, which could advance health literacy and mitigate well-known disparities in the accessibility of health-protective information. In this study, we highlight an important limitation of basic approaches to AI-powered text simplification: when given a zero-shot or one-shot simplification prompt, GPT-4 often responds by omitting critical details. To address this limitation, we developed a new prompting strategy, which we term rubric prompting. Rubric prompts involve a combination of a zero-shot simplification prompt with brief reminders about important topics to address. Using rubric prompts, we generate recommendations about cardiovascular disease prevention that are more complete, more readable, and have lower syntactic complexity than baseline responses produced without prompt engineering. This analysis provides a blueprint for rigorous evaluation of AI model outputs in medicine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr Dexter was supported by a Harvard Data Science Fellowship. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
